Clinical Trials Logo

Filter by:
NCT ID: NCT05359549 Completed - Missing Teeth Clinical Trials

Dental Implant Treatment for Two Adjacent Teeth in the Maxillary Aesthetic Region: an Evaluation After 10 Years

2implants
Start date: October 6, 2022
Phase:
Study type: Observational [Patient Registry]

- Background Replacement of two missing adjacent teeth is considered a difficult treatment in implant dentistry and even more challenging if located in the anterior region due to aesthetic demands. As well peri-implant bone contour as soft tissue volume is compromised at start of the treatment and difficult to restore. The question is if this reconstruction will be stable in the longterm. Full-scale evaluation of adjacent implant placement with crown rehabilitation in the aesthetic region with a follow-up of at least 10 years is underreported in this field of implant dentistry. - Main research question The aim of this observational study was to analyze peri-implant bone changes, mucosa levels, aesthetic ratings and patient-reported satisfaction with the maxillary aesthetic region following implant placement with crown restoration after a 10-years follow-up period. - Design (including population, confounders/outcomes) The study design is an observational study of a group of patients with two missing adjacent teeth in the maxillary aesthetic region which was treated 10 years ago with dental implant placement and an implant-supported restorations. Outcomes: primary outcome is the change in marginal peri-implant bone level 10 years after placing the definitive restoration. Secondary outcome measures will be implant and restoration survival and changes in interproximal peri-implant mucosa, midfacial peri-implant mucosal level , aesthetic outcome assessed by means of an objective index and patients' satisfaction using a questionnaire. • Expected results Stable peri-implant bone levels, stable peri-implant soft tissue levels, high implant and restoration survival rate and satisfied patients.

NCT ID: NCT05358717 Recruiting - Huntington Disease Clinical Trials

A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

Start date: April 25, 2022
Phase: Phase 2
Study type: Interventional

The primary goal of this study is to evaluate the safety and pharmacodynamic effects of PTC518 compared with placebo in participants with HD.

NCT ID: NCT05357807 Active, not recruiting - Morbid Obesity Clinical Trials

Extending and Banding the Roux-en-Y Gastric Bypass

UPGRADE
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The Roux-en-Y gastric bypass (RYGB) has proven to be an effective treatment for morbid obesity by reducing weight and comorbidities. Extending the pouch may improve weightloss without the increase of complications. Some patients regain weight after initially good weightloss. Placing a minimizer around the pouch may prevent weight regain.

NCT ID: NCT05357638 Recruiting - Multiple Sclerosis Clinical Trials

Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body

HersenFIT
Start date: May 2, 2022
Phase: N/A
Study type: Interventional

People with Parkinson's disease and Multiple Sclerosis experience disabling motor and non-motor symptoms, which respond insufficiently to medication. To adequately alleviate disease burden, physical training is increasing acknowledged as an assisting therapy; however, the optimal dose of exercise in unknown.

NCT ID: NCT05356260 Active, not recruiting - Clinical trials for Lower Urinary Tract Symptoms

Self-management Compared to Care-as-usual for Men With Lower Urinary Tract Symptoms

Start date: April 8, 2022
Phase: N/A
Study type: Interventional

Research question: Does offering an online self-management program lead to more efficient use of care by men with urinary complaints? Hypothesis: Many men with urinary symptoms receive medication from their GP. Advice on how to self-manage complaints is often skipped. This while self-management is effective. By offering self-management instead of visiting a GP the use of care by men with urinary complaints may decrease and treatment may become more efficient. Study design: Men are randomized to receive either care-as-usual by their GP or the online self-management program. Men will be followed for six months and the cost-effectiveness of the online self-management intervention will be compared to the care-as-usual

NCT ID: NCT05354453 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0001)

Start date: May 23, 2022
Phase: Phase 1
Study type: Interventional

This trial starts the clinical development of BI 1839100. Effects of single rising doses of BI 1389100 on safety, tolerability and pharmacokinetics will be assessed as basis for further development in patients with pulmonary fibrosis.

NCT ID: NCT05354440 Active, not recruiting - Prostate Cancer Clinical Trials

Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System

CLP-10441
Start date: January 1, 2022
Phase:
Study type: Observational

Long-Term Prospective Post Marketing Clinical Follow Up for Evaluation of the BioProtect Balloon Implantâ„¢ System

NCT ID: NCT05354310 Recruiting - Aging Clinical Trials

The VOILA Intervention Study

VOILA
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The multi-disciplinary and translational VOILA project presents a unique intersection between gut, immuno-metabolic, and musculoskeletal health. The main goals of the project are to develop biomarkers for healthy aging and prevent disease by maintaining quality of life in older adults. Within this umbrella project, the multimodal VOILA lifestyle intervention study will assess the impact of a twelve-week strength training and nutritional intervention in older adults with different degrees of mobility. The study will improve the current understanding of the complex relationship between gut and muscle health in different segments of mobility and obtain an insight into the heterogeneity of responsiveness between individuals.

NCT ID: NCT05354245 Recruiting - Insulin Resistance Clinical Trials

Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)

DISTAL
Start date: September 8, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of a fibre mixture added to a high-protein diet on metabolic, gut and brain health.

NCT ID: NCT05353595 Completed - Clinical trials for Muscle Protein Synthesis

The Effect of Mealworm Protein Ingestion on Muscle Protein Synthesis After Running Exercise in Humans

Centurion
Start date: June 3, 2022
Phase: N/A
Study type: Interventional

Rationale: Consumption of sufficient dietary protein is fundamental to skeletal muscle mass maintenance and overall health. Conventional animal-based protein sources such as meat, poultry, fish, eggs, and dairy are considered high-quality sources of dietary protein. However, the production of sufficient amounts of these conventional animal-based proteins to meet future global food demands will be challenging. Consequently, there is a great interest in more sustainable alternatives for these high-quality protein sources. Edible insects have recently been proposed as a high quality source of dietary protein. Insects are produced on a more viable and sustainable commercial scale and, as such, may contribute to ensuring global food security. Insect derived proteins represent a protein source that combines high quality with a (more) sustainable production. Though insect proteins have been suggested as a solution to secure future global dietary protein needs, there little data to support the bioavailability of insect derived proteins and their capacity to stimulate post-exercise muscle protein synthesis rates in vivo in humans. Objective: To assess the impact of ingesting mealworm derived protein on muscle protein synthesis rates during recovery from aerobic exercise in a group healthy men and women Study design: randomized, counter-balanced, cross-over design Study population: 20 healthy lean (BMI 18.5-30 kg/m2) young males and females (age: 18-35 y inclusive). Intervention: Subjects will perform running exercise and consume either 0.38 g per kg bodyweight mealworm protein or a non-caloric placebo. In addition, continuous intravenous tracer infusions will be applied, with plasma and muscle samples collected. Main study parameters/endpoints: The primary outcome will be post-exercise muscle protein synthesis rates following beverage ingestion.